14-005
Showing 1 - 25 of >10,000
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- BEA 2180 BR
- +2 more
-
Jasper, Alabama
- +177 more
Jul 30, 2021
Pain, Tumors, Chronic Pain Trial in Worldwide (Cebranopadol, Morphine Prolonged Release)
Terminated
- Pain
- +2 more
- Cebranopadol
- Morphine Prolonged Release
-
Vienna, Austria
- +41 more
Jul 13, 2021
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
QUILT-3.032 and of QUILT-2.005
Terminated
- Pharmacokinetics
- BCG in Combination with N-803
- N-803 alone
-
Los Angeles, California
- +5 more
Jan 20, 2021
COVID-19 Trial in India (101-PGC-005, Dexamethasone)
Recruiting
- COVID-19
-
Srikakulam, Andhra Pradesh, India
- +4 more
Jan 31, 2023
Multiple Myeloma, Renal Failure Trial in Worldwide (Data collection)
Active, not recruiting
- Multiple Myeloma
- Renal Failure
- Data collection
-
Alger, Algeria
- +32 more
Feb 7, 2022
Sepsis Trial in Nanjing (SY-005, Placebo)
Recruiting
- Sepsis
- SY-005
- Placebo
-
Nanjing, Jiangsu, ChinaZhongda Hospital,Affiliated to Southeast University
Feb 27, 2022
Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)
Not yet recruiting
- Endometrial Cancer
- MK-2870
- +2 more
- (no location specified)
Nov 10, 2023
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Psoriasis Vulgaris Trial in United States (Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%, Enstilar® foam
Completed
- Psoriasis Vulgaris
- Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%
- +2 more
-
Encinitas, California
- +29 more
Aug 17, 2020
ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)
Completed
- ASCVD
- +2 more
- Inclisiran Sodium
- Placebo
-
Chomutov, Czechia
- +69 more
Aug 3, 2020
Amyotrophic Lateral Sclerosis Trial in Boston (SLS-005, Matching Placebo)
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- SLS-005
- Matching Placebo
-
Boston, MassachusettsHealey Center for ALS at Mass General
Mar 22, 2022
Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide
Recruiting
- Uterine Cervical Neoplasms
- +10 more
- Pembrolizumab/Vibostolimab Co-Formulation
- +11 more
-
Anchorage, Alaska
- +65 more
Jan 27, 2023
Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)
Not yet recruiting
- Schizophrenia
- Schizoaffective Disorder
- (no location specified)
Mar 24, 2023
Type2 Diabetes Trial in United States (Omnipod 5 Automated Glucose Control System)
Recruiting
- Type2 Diabetes
- Omnipod 5 Automated Glucose Control System
-
Santa Barbara, California
- +6 more
Apr 19, 2023
Covid19 Trial in Japan (Novaferon, Placebo)
Recruiting
- Covid19
- Novaferon
- Placebo
-
Chiba, Japan
- +21 more
Jan 13, 2022
Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)
Active, not recruiting
- Glucocorticoids Toxicity
- +3 more
-
Bangalore, Karnataka, IndiaICBio Clinical Research Pvt. Ltd.
Dec 13, 2022
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
COPD, COPD Trial in Edegem, Erpent (GP MDI (PT001) 14.4 µg, FF MDI (PT005) 9.6 µg)
Completed
- COPD, Chronic Obstructive Pulmonary Disease
- GP MDI (PT001) 14.4 μg
- FF MDI (PT005) 9.6 μg
-
Edegem, Belgium
- +1 more
Jun 28, 2019
Wounds and Injuries, Lacerations, Surgical Incision Trial in Worldwide (MAR-CUTIS, Dermabond Advanced)
Terminated
- Wounds and Injuries
- +2 more
- MAR-CUTIS
- Dermabond Advanced
-
Amiens, France
- +18 more
Aug 10, 2020
Impacted Third Molar Tooth, Impacted Tooth Trial in Istanbul (Single-Session Bilateral Mandibular Third Molar Extraction,
Completed
- Impacted Third Molar Tooth
- Impacted Tooth
- Single-Session Bilateral Mandibular Third Molar Extraction
- Two-Session Bilateral Mandibular Third Molar Extraction
-
Istanbul, TurkeyMarmara University School of Dentistry
Apr 6, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- Placebo
-
Phoenix, Arizona
- +137 more
Jan 27, 2023